Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy
- PMID: 21487334
- DOI: 10.1097/IAE.0b013e31820f4b39
Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy
Abstract
Purpose: To evaluate the subfoveal choroidal thickness in the fellow eyes of patients with CSC, a disease often associated with choroidal vascular hyperpermeability even in eyes without subretinal fluid.
Methods: In this observational cross-sectional study, we measured the bilateral subfoveal choroidal thickness in patients with unilateral CSC using enhanced depth imaging spectral-domain optical coherence tomography. Areas of choroidal vascular hyperpermeability were visualized with indocyanine green angiography.
Results: Sixty-six consecutive Japanese patients (50 men, 16 women; mean age, 52.8 years) with unilateral CSC were examined. The subfoveal choroid in symptomatic eyes was significantly thicker than that in fellow eye (414 ± 109 μm vs. 350 ± 116 μm, P < 0.001, respectively). The subfoveal choroid of eyes with choroidal vascular hyperpermeability was 410 ± 92 μm, which differed significantly (P < 0.001) from the choroid (239 ± 59 μm) of fellow eyes without choroidal vascular hyperpermeability.
Conclusion: The subfoveal choroid in the fellow eyes of patients with CSC was thicker in the eyes with choroidal vascular hyperpermeability. Enhanced depth imaging spectral-domain optical coherence tomography can assess the effects of choroidal vascular hyperpermeability by measuring the choroidal thickness noninvasively.
Similar articles
-
Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.Ophthalmology. 2012 Aug;119(8):1666-78. doi: 10.1016/j.ophtha.2012.02.021. Epub 2012 Apr 21. Ophthalmology. 2012. PMID: 22521082
-
Choroidal thickness in central serous chorioretinopathy.Retina. 2013 Feb;33(2):302-8. doi: 10.1097/IAE.0b013e318263d11f. Retina. 2013. PMID: 23064424
-
Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.Ophthalmology. 2010 Sep;117(9):1792-9. doi: 10.1016/j.ophtha.2010.01.023. Epub 2010 May 15. Ophthalmology. 2010. PMID: 20472289
-
[Evaluation of the choroid in central serous chorioretinopathy].Nippon Ganka Gakkai Zasshi. 2012 Nov;116(11):1062-79. Nippon Ganka Gakkai Zasshi. 2012. PMID: 23316655 Review. Japanese.
-
Central serous chorioretinopathy and the sclera: what we have learned so far.Jpn J Ophthalmol. 2024 Sep;68(5):419-428. doi: 10.1007/s10384-024-01101-2. Epub 2024 Aug 16. Jpn J Ophthalmol. 2024. PMID: 39150610 Free PMC article. Review.
Cited by
-
Automatic segmentation of the choroid in enhanced depth imaging optical coherence tomography images.Biomed Opt Express. 2013 Mar 1;4(3):397-411. doi: 10.1364/BOE.4.000397. Epub 2013 Feb 11. Biomed Opt Express. 2013. PMID: 23504041 Free PMC article.
-
Choroidal modifications assessed by means of choroidal vascularity index after oral eplerenone treatment in chronic central serous chorioretinopathy.Eye (Lond). 2023 Apr;37(6):1214-1218. doi: 10.1038/s41433-022-02091-6. Epub 2022 May 19. Eye (Lond). 2023. PMID: 35590104 Free PMC article.
-
Choroidal vascularity index in different types of central serous chorioretinopathy: A meta-analysis.PLoS One. 2023 Jul 27;18(7):e0289186. doi: 10.1371/journal.pone.0289186. eCollection 2023. PLoS One. 2023. PMID: 37498843 Free PMC article.
-
Morphological differences of choroid in central serous chorioretinopathy determined by ultra-widefield optical coherence tomography.Graefes Arch Clin Exp Ophthalmol. 2022 Jan;260(1):295-301. doi: 10.1007/s00417-021-05380-0. Epub 2021 Aug 19. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 34410483
-
The suprachoroidal space: from potential space to a space with potential.Clin Ophthalmol. 2016 Jan 25;10:173-8. doi: 10.2147/OPTH.S89784. eCollection 2016. Clin Ophthalmol. 2016. PMID: 26869750 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources